NOAH Compendium

Printed from NOAH Compendium (https://www.noahcompendium.co.uk). (c) Copyright NOAH Compendium 2024. All Rights Reserved.
Date: Saturday, May 18, 2024 13:45

Description: MSD-AH
Telephone: 01908 685685 (Customer Support Centre)
Release 6.58
Nobilis® Rismavac
 
Species: Chickens, Poultry
Therapeutic indication: Immunological veterinary medical products: For chickens
Active ingredient: Vaccine Antigens
Product:Nobilis® Rismavac
Product index: Nobilis® Rismavac
Poultry - meat: Zero days
Incorporating:
Qualitative and quantitative composition
Live cell associated Marek’s disease virus strain CVI988 ≥ 3.0 log10 TCID50
For the full list of excipients, see section 6.1.
Pharmaceutical form
Deep frozen suspension for injection after dilution and diluent.
Clinical particulars
Target Species
Chickens.
Indications for use
For the vaccination of chickens against Marek’s disease.
Contraindications
None.
Special warnings for each target species
None.
Special precautions for use
Only healthy birds should be vaccinated.
The vaccine virus spreads; care should be taken to prevent such spread in multi-age sites.
Operator warnings
The operator should be aware of the general precautions to be taken when handling liquid nitrogen and/or material at very low temperature. Ampoules may explode on sudden temperature changes; therefore the operator should protect himself with gloves and a visor. When removing an ampoule from a cane hold the palm of a gloved hand away from body and face.
First aid treatment of frost bite injuries: Warm affected part by immersion in water at 29 ± 1 ºC or use body heat. There will be considerable pain during warming, but this is normal. Do not rub affected area, seek medical advice.
After handling vaccine operators should wash and disinfect hands with an approved disinfectant.
Adverse Reactions
None.
Use during pregnancy or lactation
Not to be used for birds in lay.
Interactions
Safety and efficacy data are available which demonstrate that Nobilis Rismavac can be mixed in the same solvent and administered by the subcutaneous route either with Innovax-ILT or Innovax-ND-IBD or Innovax-ND-ILT. For this mixed use, an onset of immunity of 5 days has been demonstrated for MD.
No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.
Amounts to be administered and administration route
Preparation:
For use the ampoule of vaccine is thawed, by placing in water at room temperature (not hot or icy cold). When the vaccine has thawed the ampoule is opened immediately and diluted in the solvent using a sterile syringe allowing 1000 doses of vaccine to each 200 ml of fluid.
Administration:
Administer by a single injection of 0.2 ml subcutaneously in the neck or intramuscularly in the leg, after reconstitution in the solvent provided. Injection should be made using an approved repeating syringe or automatic vaccinator.
A needle of 20G * ½” should be used to inject the birds.
Equipment used for vaccination should be sterile and contain no traces of detergents or disinfectants.
Overdose
No specific treatment or antidote recommended.
Withdrawal periods
Zero days.
Pharmacological particulars
ATC Vet Code: QI01AD03.
Pharmacotherapeutic group
Immunologicals for aves, Domestic fowl, Live viral vaccines.
The vaccine contains live, cell-associated Marek's disease virus for parenteral administration to chickens to stimulate active immunity against the disease.
Pharmaceutical particulars
Excipients
Cell concentrate:
Bovine serum
Veggie medium
Dimethyl sulfoxide
Solvent:
Sucrose
Sodium Chloride
Disodium hydrogen phosphate dihydrate
Phenolsulfonphtalein (Phenol red)
Potassium dihydrogen phosphate Water for injections
Major incompatibilities
Do not mix with any other veterinary medicinal product except Innovax-ILT or Innovax-ND-IBD or Innovax-ND-ILT and the solvent supplied for use with this medicinal product.
Shelf-life
Vaccine
Shelf life of the cell concentrate as packed for sale: 5 years.
Shelf life after dilution or reconstitution according to directions: 2 hours at +2ºC to +8 ºC.
Solvent:
Shelf life of the solvent (multilayer plastic bags) as packaged for sale: 3 years.
Special precautions for storage
Cell concentrate:
Store and transport frozen in liquid nitrogen at a temperature below ≤ -150oC.
Thawed ampoules must not be refrozen.
Do not expose reconstituted vaccine to direct sunlight or heat.
Solvent:
Store below 30°C.
Container:
Store liquid nitrogen container securely in an upright position in a clean, dry and well-ventilated room separated from the hatching/chicken room
Immediate packaging
Cell concentrate:
1,000, 2,000, 4,000 and 5,000 dose ampoules of hydrolytical class type I (Ph. Eur.) glass containing the cell suspension. The ampoules are heat sealed.
The ampoules are inserted in metal canes and shipped and stored in a liquid nitrogen container.
Solvent:
- One 200 ml multilayer plastic bag.
- One 400 ml multilayer plastic bag.
- One 500 ml multilayer plastic bag.
- One 600 ml multilayer plastic bag.
- One 800 ml multilayer plastic bag.
- One 1000 ml multilayer plastic bag.
- One 1200 ml multilayer plastic bag.
- One 1600 ml multilayer plastic bag.
Not all pack sizes may be marketed.
Disposal
Dispose of waste material by boiling, incineration or immersion in an appropriate disinfectant, approved for use by the competent authorities.
Marketing Authorisation Number
UK: Vm 01708/4294
Significant changes
Date of the first authorisation or date of renewal
19 August 2008.
Date of revision of the text
July 2022.
Any other information
For animal treatment only. Keep out of the sight and reach of children.
Legal category
Legal category: POM-VPS
GTIN
GTIN description:Nobilis Rismavac 1x1000ds/2ml:
GTIN:08713184085122